ID   ONE58
AC   CVCL_2671
DR   BioSample; SAMN07624412
DR   BioSamples; SAMEA100744
DR   cancercelllines; CVCL_2671
DR   CBA; CBA-0143
DR   Cosmic; 1522773
DR   Cosmic; 1963332
DR   DepMap; ACH-001992
DR   ECACC; 10092313
DR   GEO; GSM726282
DR   Progenetix; CVCL_2671
DR   Wikidata; Q54936408
RX   PubMed=1703129;
RX   PubMed=21642991;
RX   PubMed=25902174;
RX   PubMed=28387650;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Mutation; HGNC; 3373; EP300; Simple; p.Gln1993Ter (c.5797C>T); Zygosity=Heterozygous (DepMap=ACH-001992).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Tyr205Cys (c.614A>G); ClinVar=VCV000376681; Zygosity=Homozygous (DepMap=ACH-001992).
CC   Transformant: ChEBI; CHEBI:46666; Crocidolite asbestos.
CC   Omics: Secretome proteome analysis.
CC   Omics: SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CBA=CBA-0143
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 11,12
ST   D19S433: 12
ST   D21S11: 30,31.2
ST   D2S1338: 20,23
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 7,11
ST   D8S1179: 10,13
ST   FGA: 21
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 21
//
RX   PubMed=1703129; DOI=10.1002/ijc.2910470219;
RA   Manning L.S., Whitaker D., Murch A.R., Garlepp M.J., Davis M.R.,
RA   Musk A.W., Robinson B.W.S.;
RT   "Establishment and characterization of five human malignant
RT   mesothelioma cell lines derived from pleural effusions.";
RL   Int. J. Cancer 47:285-290(1991).
//
RX   PubMed=21642991; DOI=10.1038/ng.855; PMCID=PMC4643098;
RA   Bott M.J., Brevet M., Taylor B.S., Shimizu S., Ito T., Wang L.,
RA   Creaney J., Lake R.A., Zakowski M.F., Reva B., Sander C., Delsite R.,
RA   Powell S.N., Zhou Q., Shen R.-L., Olshen A.B., Rusch V.W., Ladanyi M.;
RT   "The nuclear deubiquitinase BAP1 is commonly inactivated by somatic
RT   mutations and 3p21.1 losses in malignant pleural mesothelioma.";
RL   Nat. Genet. 43:668-672(2011).
//
RX   PubMed=25902174; DOI=10.1097/JTO.0000000000000493;
RA   Miyanaga A., Masuda M., Tsuta K., Kawasaki K., Nakamura Y., Sakuma T.,
RA   Asamura H., Gemma A., Yamada T.;
RT   "Hippo pathway gene mutations in malignant mesothelioma: revealed by
RT   RNA and targeted exon sequencing.";
RL   J. Thorac. Oncol. 10:844-851(2015).
//
RX   PubMed=28387650; DOI=10.21873/cgp.20023; PMCID=PMC5369310;
RA   Creaney J., Dick I.M., Leon J.S., Robinson B.W.S.;
RT   "A proteomic analysis of the malignant mesothelioma secretome using
RT   iTRAQ.";
RL   Cancer Genomics Proteomics 14:103-117(2017).
//